Skip to main content
A Bold Vision Header

Rethinking Cardiovascular Risk in Europe

Welcome to Amarin

Amarin Corporation plc is a rapidly growing, innovative pharmaceutical company focused on developing and commercializing therapeutics to cost-effectively improve cardiovascular health.

Employees smiling within a work setting

Work for Amarin

Our mission to help transform the lives of cardiovascular patients in Europe is only just beginning and if you share our passion for innovation and improving patient care, we want to hear from you.

Experienced male male doctor smiling at female patient

About Us

At Amarin, we are committed to improving the lives of high-risk cardiovascular patients across Europe by establishing a new treatment for cardiovascular disease.


Here you will find our latest European press releases and media contact details

MARCH 2021

The European Commission gives green light to a proven new treatment to reduce cardiovascular events such as heart attacks, strokes and cardiac deaths

Employee on phone smiling


For general enquires and requests for further information, please email us at [email protected]